Adamis Pharmaceuticals Corp (ADMP): I would prefer the optimist route...once...

Featured News Placeholder

With Prime Featured, display your headline and ticker symbol on the pages where our users live.

Featured News Placeholder

Premium Featured gets you a step above: Your logo + Your Headline + Your Ticker + Our Audience = Perfection.

Adamis Pharmaceuticals Corp (ADMP)

Reply Private New

Next 10 Prev Next

Send PM

Followers	28
Posts	1014
Boards Moderated	0
Alias Born	03/10/2014

FREE
ADMP REPORT

Re: Ruffieruff post# 1777

Wednesday, 10/02/2019 3:16:28 PM

Wednesday, October 02, 2019 3:16:28 PM

I would prefer the optimist route...once Q3 revenues are released, this should start headed northward of $1 again. With all the lawsuits finally behind us, and a turn towards cash flow positive, there is no reason not to start turning green.

As it already appears that a possible CRL has been priced in, I cant see this getting much lower, if at all. So if we get approval on the PDFUA on Halloween as planned...or sooner, I see no reason we won’t at least double in one session. That and an agreement with a large up front payment could make this lucrative in no time.

Well...Here’s to Optimism!

In My Own Personal Opinion Of Course!

Next 10 Prev Next

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:

1D
1M
3M
6M
1Y
5Y

Detailed Quote

Recent ADMP News

Quarterly Report (10-q) • Edgar (US Regulatory) • 11/14/2022 09:59:00 PM
Current Report Filing (8-k) • Edgar (US Regulatory) • 11/14/2022 09:48:05 PM
Adamis Pharmaceuticals Reports Third Quarter 2022 Financial Results and Provides Corporate Update • GlobeNewswire Inc. • 11/14/2022 09:10:07 PM
Adamis Pharmaceuticals Schedules Third Quarter 2022 Financial Results Conference Call and Corporate Update • GlobeNewswire Inc. • 11/07/2022 09:05:00 PM
Current Report Filing (8-k) • Edgar (US Regulatory) • 10/04/2022 10:16:15 AM
Current Report Filing (8-k) • Edgar (US Regulatory) • 10/04/2022 10:09:16 AM
Adamis Announces Review of Strategic Alternatives • GlobeNewswire Inc. • 10/03/2022 08:30:00 PM
Current Report Filing (8-k) • Edgar (US Regulatory) • 09/23/2022 09:08:52 PM
Prospectus Filed Pursuant to Rule 424(b)(5) (424b5) • Edgar (US Regulatory) • 09/23/2022 09:06:45 PM
Adamis Provides Update on the Phase 2/3 Trial of Tempol in COVID-19 Positive High-Risk Subjects • GlobeNewswire Inc. • 09/21/2022 11:30:00 AM
Notice of Effectiveness (effect) • Edgar (US Regulatory) • 09/20/2022 10:03:49 AM
Adamis Provides an Enrollment Update on the Phase 2/3 Study of Tempol in COVID-19 Positive High-Risk Subjects • GlobeNewswire Inc. • 09/12/2022 08:05:00 PM
Current Report Filing (8-k) • Edgar (US Regulatory) • 09/12/2022 10:05:18 AM
Securities Registration Statement (simplified Form) (s-3) • Edgar (US Regulatory) • 09/09/2022 09:13:00 PM
Additional Proxy Soliciting Materials (definitive) (defa14a) • Edgar (US Regulatory) • 08/18/2022 07:09:02 PM
Additional Proxy Soliciting Materials (definitive) (defa14a) • Edgar (US Regulatory) • 08/15/2022 10:36:44 AM
Adamis Pharmaceuticals Announces Results of Annual Meeting of Stockholders • GlobeNewswire Inc. • 08/12/2022 09:00:00 PM
Current Report Filing (8-k) • Edgar (US Regulatory) • 08/10/2022 08:11:23 PM
Quarterly Report (10-q) • Edgar (US Regulatory) • 08/10/2022 08:05:21 PM
Adamis Pharmaceuticals Reports Second Quarter 2022 Financial Results and Provides Corporate Update • GlobeNewswire Inc. • 08/10/2022 08:02:00 PM
Adamis Pharmaceuticals Schedules Second Quarter 2022 Financial Results Conference Call and Corporate Update • GlobeNewswire Inc. • 08/08/2022 11:30:00 AM
Current Report Filing (8-k) • Edgar (US Regulatory) • 08/01/2022 01:38:08 PM
Dawson James Sticks to Its Hold Rating for Adamis Pharma (ADMP) • TipRanks • 07/31/2022 12:15:25 PM
Additional Proxy Soliciting Materials (definitive) (defa14a) • Edgar (US Regulatory) • 07/29/2022 07:36:42 PM
Leading Independent Proxy Advisory Firm ISS Recommends Adamis Pharmaceuticals’ Stockholders Vote FOR Critical Proposals at Upcoming Annual Meeting • GlobeNewswire Inc. • 07/29/2022 12:00:00 PM

More ADMP News

InvestorsHub NewsWire

TNRG Signs Reg A Offering Agreement • TNRG • Feb 3, 2023 10:30 AM

Trend Innovations Holding Inc. Thy News Application Review Year 2022 and Update Toward 2023 • TREN • Feb 2, 2023 2:00 PM

Goldshore Intersects 9.46 g/t Au over 7.45m in the Southwest Zone Widths of Mineralized System Expanded Significantly. • GSHRF • Feb 2, 2023 9:58 AM

Hempacco and Snoop Dogg Create Joint Venture to Launch Consumer Goods Powerhouse of Hemp and Hemp-Derived Products • HPCO • Feb 2, 2023 9:30 AM

Kona Gold Beverage, Inc Announces Record Revenue Month in January Eclipsing Half a Million Dollars for the First Time • KGKG • Feb 2, 2023 9:00 AM

BioLife Sciences Inc. (OTC: BLFE) Announces Letter of Intent for Exclusive Licensing Deal with Canadian Firm • BLFE • Feb 2, 2023 8:32 AM

Start posting your company's news

Only $200 per official company press release!